Teladoc Mergers and Acquisitions Presentation Deck
Summary Financial Forecast Pre-Synergies (Prepared in Connection with
Merger)
Teladoc Financial Projections
Total Revenue
Adj. Gross Profit²
Adj. EBITDA3
Teladoc Management-Adjusted Livongo Projections:
Total Revenue
Year Ending December 31 ($ in Millions)
2020¹
Non-GAAP Gross Profit4
Teladoc. Livongo®
HEALTH
$988
609
89
2021
O Teladoc Health, Inc. All rights reserved.
$1,338
853
154
2022
$1,739
1,116
244
$351
$567
266
431
Adj. EBITDA5
37
71
229
Source: Preliminary S-4 filed on September 3, 2020. While Teladoc provides limited near-term guidance each quarter, Teladoc does not, as a matter of course, publicly disclose forecasts or projections as to future performance,
earnings or other results due to the inherent unpredictability of projections and their underlying assumptions and estimates.
$892
678
134
2023
$2,192
1,397
362
$1,257
957
36View entire presentation